On Feb. 10, 1959, the FDA announced that nasal inhalers containing basic amphetamine can be sold only by prescription. Previously this product (used for relieving nasal congestion) had been sold directly to the public.

Basic amphetamine has been replaced by safer, more effective prescription and over-the-counter (OTC) products for relieving nasal congestion.